Publications
Here you can browse the complete list of publications for studies listed on CDAS.
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| Using Metabolomics to Explore the Role of Postmenopausal Adiposity in Breast Cancer Risk. | 29325156 | Lasky-Su JA, Zeleznik OA, Eliassen AH | J. Natl. Cancer Inst. | 2018 | PLCO |
| Circulating cotinine concentrations and lung cancer risk in the Lung Cancer Cohort Consortium (LC3). | 29901778 | Larose TL, Guida F, Fanidi A, Langhammer A, Kveem K, Stevens VL, Jacobs EJ, Smith-Warner SA, Giovannucci E, Albanes D, Weinstein SJ, Freedman ND, Prentice R, Pettinger M, Thomson CA, Cai Q, Wu J, Blot WJ, Arslan AA, Zeleniuch-Jacquotte A, Le Marchan… | Int J Epidemiol | 2018 | PLCO |
| Circulating Selenium and Prostate Cancer Risk: A Mendelian Randomization Analysis. | 29788239 | Yarmolinsky J , Bonilla C , Haycock PC , Langdon RJQ , Lotta LA , Langenberg C , Relton CL , Lewis SJ , Evans DM , PRACTICAL Consortium , Davey Smith G , Martin RM | J. Natl. Cancer Inst. | 2018 | PLCO |
| Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Esophageal/Gastric Cardia Adenocarcinoma Among Men. | 29788475 | Petrick JL, Hyland PL, Caron P, Falk RT, Pfeiffer RM, Dawsey SM, Abnet CC, Taylor PR, Weinstein SJ, Albanes D, Freedman ND, Gapstur SM, Bradwin G, Guillemette C, Campbell PT, Cook MB | J. Natl. Cancer Inst. | 2018 | PLCO |
| Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors. | 29458155 | Jeon J, Du M, Schoen RE, Hoffmeister M, Newcomb PA, Berndt SI, Caan B, Campbell PT, Chan AT, Chang-Claude J, Giles GG, Gong J, Harrison TA, Huyghe JR, Jacobs EJ, Li L, Lin Y, Le Marchand L, Potter JD, Qu C, Bien SA, Zubair N, Macinnis RJ, Buchanan D… | Gastroenterology | 2018 | PLCO |
| Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. | 29892050 | Dadaev T, Saunders EJ, Newcombe PJ, Anokian E, Leongamornlert DA, Brook MN, Cieza-Borrella C, Mijuskovic M, Wakerell S, Olama AAA, Schumacher FR, Berndt SI, Benlloch S, Ahmed M, Goh C, Sheng X, Zhang Z, Muir K, Govindasami K, Lophatananon A, Stevens… | Nat Commun | 2018 | PLCO |
| Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. | 29892016 | Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, Tyrer J, Muir K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tange… | Nat. Genet. | 2018 | PLCO |
| A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium. | 29114882 | Barrdahl M, Canzian F, Gaudet MM, Gapstur SM, Trichopoulou A, Tsilidis K, van Gils CH, Borgquist S, Weiderpass E, Khaw KT, Giles GG, Milne RL, Le Marchand L, Haiman C, Lindström S, Kraft P, Hunter DJ, Ziegler R, Chanock SJ, Yang XR, Buring JE, Lee I… | Int. J. Cancer | 2018 | PLCO |
| Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus. | 30033361 | Gao P, Xia JH, Sipeky C, Dong XM, Zhang Q, Yang Y, Zhang P, Cruz SP, Zhang K, Zhu J, Lee HM, Suleman S, Giannareas N, Liu S, PRACTICAL Consortium, Tammela TLJ, Auvinen A, Wang X, Huang Q, Wang L, Manninen A, Vaarala MH, Wang L, Schleutker J, Wei GH | Cell | 2018 | PLCO |
| AA9int: SNP interaction pattern search using non-hierarchical additive model set. | 29878078 | Lin HY, Huang PY, Chen DT, Tung HY, Sellers TA, Pow-Sang JM, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Hamdy F, Neal DE, Pashayan N, Kh… | Bioinformatics | 2018 | PLCO |
| Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium. | 29438364 | Lophatananon A, Stewart-Brown S, Kote-Jarai Z, Al Olama AA, Garcia SB, Neal DE, Hamdy FC, Donovan JL, Giles GG, Fitzgerald LM, Southey MC, Pharoah P, Pashayan N, Gronberg H, Wiklund F, Aly M, Stanford JL, Brenner H, Dieffenbach AK, Arndt V, Park JY,… | Br. J. Cancer | 2018 | PLCO |
| Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts. | 29321194 | Seibert TM, Fan CC, Wang Y, Zuber V, Karunamuni R, Parsons JK, Eeles RA, Easton DF, Kote-Jarai Z, Al Olama AA, Garcia SB, Muir K, Grönberg H, Wiklund F, Aly M, Schleutker J, Sipeky C, Tammela TL, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, … | BMJ | 2018 | PLCO |
| Use of Time and Energy on Exercise, Prolonged TV Viewing, and Work Days. | 30031635 | Matthews CE, Keadle SK, Saint-Maurice PF, Moore SC, Willis EA, Sampson JN, Berrigan D | Am J Prev Med | 2018 | IDATA |
| Measurement of Active and Sedentary Behavior in Context of Large Epidemiologic Studies. | 28930863 | Matthews CE, Kozey Keadle S, Moore SC, Schoeller DS, Carroll RJ, Troiano RP, Sampson JN | Med Sci Sports Exerc | 2018 | IDATA |
| Classification of CT Pulmonary Opacities as Perifissural Nodules: Reader Variability. | 29969076 | Schreuder A, van Ginneken B, Scholten ET, Jacobs C, Prokop M, Sverzellati N, Desai SR, Devaraj A, Schaefer-Prokop CM | Radiology | 2018 | NLST |
| Lung cancer risk to personalise annual and biennial follow-up computed tomography screening. | 29602813 | Schreuder A, Schaefer-Prokop CM, Scholten ET, Jacobs C, Prokop M, van Ginneken B | Thorax | 2018 | NLST |
| Oral Alpha, Beta, and Gamma HPV Types and Risk of Incident Esophageal Cancer. | 30087123 | Agalliu I, Chen Z, Wang T, Hayes RB, Freedman ND, Gapstur SM, Burk RD | Cancer Epidemiol. Biomarkers Prev. | 2018 | PLCO |
| Associations between obesity, smoking and lymph node status at breast cancer diagnosis in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. | 30157224 | Smith A, Mullooly M, Murphy L, Barron TI, Bennett K | PLoS ONE | 2018 | PLCO |
| The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer. | 30094676 | Miller EA, Pinsky PF, Pierre-Victor D | Cancer Causes Control | 2018 | PLCO |
| Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer. | 29978465 | Xu Y, Liu H, Liu S, Wang Y, Xie J, Stinchcombe TE, Su L, Zhang R, Christiani DC, Li W, Wei Q | Int. J. Cancer | 2018 | PLCO |